Rottinghaus Scott T.

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 78% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rottinghaus Scott T.'s trades of Enanta Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-05 2025-12-05
S Sale
15,146 +23.5%
233.22
US$2,978,402 		15,146 +23.5% 233.22 US$2,978,402
2024-12-10 2024-12-06
S Sale
8,802 -34.3%
416.20
US$2,992,893 		8,802 -34.3% 416.20 US$2,992,893
2024-07-15 2024-07-15
PlS Planned sale
51,845 -15.9%
358.89
US$3,680,385 		51,845 -15.9% 358.89 US$3,680,385
2024-07-15 2024-07-12
PlS Planned sale
2,271 -9.5%
15.04
US$34,156 		2,271 -9.5% 15.04 US$34,156
2024-07-15 2024-07-11
PlS Planned sale
4,299 -15.2%
15.07
US$64,786 		4,299 -15.2% 15.07 US$64,786
2024-07-11 2024-07-11
PrS Proposed sale
11,945
14.96
US$178,697 		11,945 14.96 US$178,697
2023-12-06 2023-12-05
S Sale
534 -2.0%
9.63
US$5,142 		534 -2.0% 9.63 US$5,142